Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas J McCown

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Current Gene Therapy|April 2, 2011
Adeno-Associated Virus (AAV) Vectors in the CNSThomas J McCown
Drug News & Perspectives|July 7, 2010
The future of epilepsy treatment: focus on adeno-associated virus vector gene therapyThomas J McCown
Current Gene Therapy|June 25, 2005
Adeno-associated virus (AAV) vectors in the CNSThomas J McCown
Expert Opinion on Biological Therapy|October 27, 2004
The clinical potential of antiepileptic gene therapyThomas J McCown
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 1, 2009
Adeno-associated virus vector-mediated expression and constitutive secretion of galanin suppresses limbic seizure activityThomas J McCown
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2006
Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivoThomas J McCown
Methods (San Diego, Calif.)|November 5, 2002
Regulation of gene expression in adeno-associated virus vectors in the brainRebecca P Haberman, Thomas J McCown
Journal of Virology|October 30, 2024
Adeno-associated virus 9 (AAV9) viral proteins VP1, VP2, and membrane-associated accessory protein (MAAP) differentially influence <i>in vivo</i> transgene expressionSara K Powell, Thomas J McCown
Experimental Neurology|October 20, 2011
Current prospects and challenges for epilepsy gene therapyMarc S Weinberg, Thomas J McCown
Neuropharmacology|April 3, 2012
Adeno-associated virus (AAV) gene therapy for neurological diseaseMarc S Weinberg, R Jude Samulski, Thomas J McCown
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Current Gene Therapy|April 2, 2011
Adeno-Associated Virus (AAV) Vectors in the CNSThomas J McCown
Drug News & Perspectives|July 7, 2010
The future of epilepsy treatment: focus on adeno-associated virus vector gene therapyThomas J McCown
Current Gene Therapy|June 25, 2005
Adeno-associated virus (AAV) vectors in the CNSThomas J McCown
Expert Opinion on Biological Therapy|October 27, 2004
The clinical potential of antiepileptic gene therapyThomas J McCown
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|April 1, 2009
Adeno-associated virus vector-mediated expression and constitutive secretion of galanin suppresses limbic seizure activityThomas J McCown
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 30, 2006
Adeno-associated virus-mediated expression and constitutive secretion of galanin suppresses limbic seizure activity in vivoThomas J McCown
Methods (San Diego, Calif.)|November 5, 2002
Regulation of gene expression in adeno-associated virus vectors in the brainRebecca P Haberman, Thomas J McCown
Journal of Virology|October 30, 2024
Adeno-associated virus 9 (AAV9) viral proteins VP1, VP2, and membrane-associated accessory protein (MAAP) differentially influence <i>in vivo</i> transgene expressionSara K Powell, Thomas J McCown
Experimental Neurology|October 20, 2011
Current prospects and challenges for epilepsy gene therapyMarc S Weinberg, Thomas J McCown
Neuropharmacology|April 3, 2012
Adeno-associated virus (AAV) gene therapy for neurological diseaseMarc S Weinberg, R Jude Samulski, Thomas J McCown
Pageof 3